Latest Growth Initiatives News

Macquarie Technology Group Limited reported solid FY25 results with continued EBITDA growth and strong cash conversion, underpinned by strategic investments in data centre capacity and AI capabilities.

Shriro Holdings reported a 13.6% revenue decline to $103.3 million in FY25 but delivered a 5.5% rise in EBITDA and an 8.7% increase in net profit after tax. The company completed a $15 million share buy-back and deferred its final dividend as it explores alternative capital uses.

Nido Education Limited reported a 7.5% increase in revenue for the half-year ending June 2025, alongside a modest net profit and a fully franked interim dividend. The company also completed a strategic acquisition to expand its childcare footprint.

Platinum Asset Management reports improved FY2025 financials alongside a transformative merger proposal with L1 Capital, aiming to create a $16.5 billion alternative asset manager.

Enlitic, Inc. reported a sharp revenue increase driven by migration services and subscription growth, while sustaining a net loss of US$6.86 million in H1 2025. The company secured a binding MOU with GE Healthcare and completed a A$10 million capital raise.

Nova Eye Medical Limited reported a 25% increase in revenue to AUD 29.3 million for FY2025, driven by strong sales in its glaucoma surgical devices segment, yet posted a net loss after tax of AUD 9.1 million. The company raised AUD 6.2 million through a share placement to support growth initiatives.

Nutritional Growth Solutions has settled to exit non-core US agreements, unlocking nearly $580,000 in financial relief and streamlining its strategic focus.

Provaris Energy has raised $1 million through a share placement to accelerate its hydrogen and CO2 storage and transport commercialisation programs, targeting new markets in Asia and Europe.

Stealth Group Holdings has reported a landmark FY25 with sales soaring 27.6% to $145.1 million and net profit more than doubling. The company’s strategic investments and operational discipline set the stage for ambitious growth targets through FY28.

archTIS Limited has reported FY25 results with solid ARR growth and completed a transformative acquisition of Spirion LLC, significantly boosting its US market presence and product suite. The company is raising $20.5 million to fund this expansion and accelerate growth.

archTIS Limited has acquired Spirion LLC’s technology, customers, and employees for A$15.7 million, significantly expanding its U.S. presence and product portfolio in data security. The deal adds A$17 million in annual recurring revenue and brings new cross-selling opportunities across a blue-chip customer base.

Compumedics has reported record-breaking sales orders and revenues for FY25, driven by strong US market growth and SaaS adoption, setting the stage for an ambitious FY26 expansion.